Soxa Formulations And Research Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 29-12-2024
- Paid Up Capital ₹ 1.06 Cr
as on 29-12-2024
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.20 Cr
as on 29-12-2024
- Revenue -3.31%
(FY 2022)
- Profit -73.05%
(FY 2022)
- Ebitda -67.14%
(FY 2022)
- Net Worth 0.76%
(FY 2022)
- Total Assets 11.39%
(FY 2022)
About Soxa Formulations And Research
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.06 Cr.
The company currently has active open charges totaling ₹7.20 Cr.
Sandipkumar Patel, Vimalkumar Patel, Bharatkumar Patel, and One other member serve as directors at the Company.
- CIN/LLPIN
U24100GJ2015PTC083021
- Company No.
083021
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Apr 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Sabarkantha, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Soxa Formulations And Research Private Limited offer?
Soxa Formulations And Research Private Limited offers a wide range of products and services, including Surgical & ICU Equipments, Dialysis Machine.
Who are the key members and board of directors at Soxa Formulations And Research?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandipkumar Patel  | Director | 25-Jul-2016 | Current |
| Vimalkumar Patel | Director | 25-Jul-2016 | Current |
| Bharatkumar Patel | Director | 25-Jul-2016 | Current |
| Brijeshkumar Patel | Director | 28-Apr-2015 | Current |
Financial Performance of Soxa Formulations And Research.
Soxa Formulations And Research Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 3.31% decrease. The company also saw a substantial fall in profitability, with a 73.05% decrease in profit. The company's net worth moved up by a moderate rise of 0.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Soxa Formulations And Research?
In 2021, Soxa Formulations And Research had a public holding of 16.42%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 May 2019 | ₹1.90 Cr | Open |
Others Creation Date: 15 Jun 2018 | ₹2.50 Cr | Open |
Others Creation Date: 05 Jun 2018 | ₹2.80 Cr | Open |
How Many Employees Work at Soxa Formulations And Research?
Unlock and access historical data on people associated with Soxa Formulations And Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Soxa Formulations And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Soxa Formulations And Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
